Get started
Author

Mingyao Huang

The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders
2022 · Sheng Zhang, Xueqiang Peng, et al. · Cell Death and Disease · 336
PDF
Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications
2022 · Guangpeng He, Xueqiang Peng, et al. · Molecular Cancer · 206
PDF
Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy
2023 · Hongyu Zheng, Xueqiang Peng, et al. · Cell Death Discovery · 127
PDF
Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells
2022 · Mingyao Huang, Xin Huang, et al. · Cancer Science · 113
Rab GTPases: Central Coordinators of Membrane Trafficking in Cancer
2021 · Hongyuan Jin, Yuanxin Tang, et al. · Frontiers in Cell and Developmental Biology · 112
PDF
Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers
2020 · Bowen Li, Liang Yang, et al. · Biomedicine & Pharmacotherapy · 104
PDF
Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies
2022 · Jiaxing Liu, Xueqiang Peng, et al. · Cell Communication and Signaling · 87
PDF
The immune checkpoint TIGIT/CD155 promotes the exhaustion of CD8 + T cells in TNBC through glucose metabolic reprogramming mediated by PI3K/AKT/mTOR signaling
2024 · Mingyao Huang, Xiaoqin Yu, et al. · Cell Communication and Signaling · 73
PDF
CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma
2021 · Bowen Li, Shibo Wei, et al. · Frontiers in Oncology · 62
Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy
2023 · Da Qian, Jialu Li, et al. · Biomedicine & Pharmacotherapy · 55
LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation
2021 · Xueqiang Peng, Xinyu Li, et al. · Journal of Experimental & Clinical Cancer Research · 54
PDF
Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy
2020 · Mingyao Huang, Liang Yang, et al. · Journal of Experimental & Clinical Cancer Research · 54
PDF
Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification
2025 · Mingyao Huang, Quansong Ji, et al. · Gut Microbes · 53
Non-coding RNA derived from extracellular vesicles in cancer immune escape: Biological functions and potential clinical applications
2020 · Mingyao Huang, Xueqiang Peng, et al. · Cancer Letters · 36
Gut microbiota reshapes the TNBC immune microenvironment: Emerging immunotherapeutic strategies
2025 · Mingyao Huang, Yikai Zhang, et al. · Pharmacological Research · 32
PDF
Tumor-derived exosomes in hypoxic microenvironment: release mechanism, biological function and clinical application
2022 · Da Qian, Yaoyao Xie, et al. · Journal of Cancer · 18
PDF
Development and Clinical Evaluation of a CRISPR-Based Diagnostic for Rapid Group BStreptococcusScreening
2021 · Lingxiao Jiang, Weiqi Zeng, et al. · Emerging infectious diseases · 14
PDF
Integrated single-cell and bulk transcriptomic analysis identifies a novel macrophage subtype associated with poor prognosis in breast cancer
2025 · Qing Wang, Yushuai Yu, et al. · Cancer Cell International · 12
Methylation modification of non-histone proteins in breast cancer: An emerging targeted therapeutic strategy
2024 · Mingyao Huang, Zirong Jiang, et al. · Pharmacological Research · 8
CAR-NK cell for gynecological cancers: immune microenvironment remodeling and immunotherapeutic strategies
2025 · Mingyao Huang, Siyang Wang, et al. · Frontiers in Immunology · 6
PDF
CD155 and its receptors in glioma: prospects for emerging immune checkpoint inhibitors
2026 · Mingyao Huang, Youchen Cui, et al. · Acta Neuropathologica Communications · 1
The PVR-TIGIT/CD96/CD226 axis: a novel immune checkpoint target in ovarian cancer
2026 · Mingyao Huang, Jiahui Zhang, et al. · Frontiers in Immunology
PDF
PEGylated PLGA Nanoformulations For Effective Immunomodulatory Actors In Non–Small Cell Lung Cancer
2026 · Mingyao Huang, Jiahui Zhang, et al. · International Journal of Nanomedicine
PDF
Abstract P2-04-02: TRIB3 regulates lipophagy and drives the metastasis of triple negative breast cancer by activation of PI3K/AKT/mTOR pathway
2025 · Zirong iang, Yushuai Yu, et al. · Clinical Cancer Research
Works count: 24
Citation count: 1,563
H-index: 16
I10-index: 18
Year
Topic
Type